Assessment of Efficiency and Safety of Phytocomposition with Prostate-Protective Properties in the form of Rectal Suppositories

Year 2024, , 407 - 425, 30.10.2024

Oleksandra Dmytrenko Tetiana Lutsenko , Andrii Dmytrenko Olena Bespalova

https://doi.org/10.28978/nesciences.1465276

Abstract

AIM: To evaluate the clinical efficiency of phytocomposition with prostate-protective properties in the form of rectal suppositories.
METHODS: The analysis of literature information was performed to assess literature data and form an evidence base for the ratio between the levels of clinical effectiveness and safety for phytocomposition with prostate-protective properties in the form of rectal suppositories. To assess the clinical efficiency and safety the authors used a literature review on the ground of databases PubMed, MEDLINE, Web of Science, and Scopus.
RESULTS: The functional characteristics of a combination of extracts of saw palmetto, lovage roots, and calendula flowers are caused by fatty acids and their derivatives (saw palmetto), essential oils, flavonoids (lovage, calendula), phenolic acids, phthalides, and bitter principles (lovage). Considering the complex effect of all components, the studied phytocomposition in the form of rectal suppositories promotes the arrest of the inflammatory process, inhibits vein micro-thrombosis in the prostate, decreases the edema and leucocytic infiltration of the prostate, and improves microcirculation processes.
CONCLUSIONS: Analyzing the scientific literature on the components of phytocomposition of rectal suppositories with prostate-protective properties, it may be concluded that the combination of extracts of saw palmetto, lovage roots, and calendula flowers has anti-inflammatory, antiproliferative, and immunomodulatory action.

Keywords

Chronic Prostatitis (CP), Benign Prostate Hyperplasia (BPH), phytopreparation, suppositories, efficiency, safety

References

• Belenichev, I., Gorchakova, N., Savchenko, N., Yakovleva, N., Varavka, I., Varvanskyi, P., & Belenichev, K. (2023). Vegetables and other adaptogens with actoprotectory properties (phytodrugs and food supplements). Fitoterapia, 3, 5–12.
• Boyle, P., Robertson, C., Lowe, F., & Roehrborn, C. (2000). Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology, 55(4), 533-539. https://doi.org/10.1016/S0090-4295(99)00593-2
• Carraro, J. C., Raynaud, J. P., Koch, G., Chisholm, G. D., Di Silverio, F., Teillac, P., & Perrin, P. (1996). Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. The Prostate, 29(4), 231-240. https://doi.org/10.1002/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E
• Chua, T., Eise, N. T., Simpson, J. S., & Ventura, S. (2014). Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): effects on rat prostate contractility. Journal of ethnopharmacology, 152(2), 283-291. https://doi.org/10.1016/j.jep.2013.12.030
• Cicero, A. F., Allkanjari, O., Busetto, G. M., Cai, T., Larganà, G., Magri, V., & Vitalone, A. (2019). Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Archivio Italiano di Urologia e Andrologia, 91(3), 139-152, https://doi.org/10.4081/aiua.2019.3.139
• Ciocarlan, A., Dragalin, I., Aricu, A., Lupaşcu, L., Ciocarlan, N., & Popescu, V. (2018). Chemical composition and antimicrobial activity of the Levisticum officinale WDJ Koch essential oil. Chemistry Journal of Moldova, 13(2), 63-68. https://doi.org/10.19261/cjm.2018.514
• Colado-Velázquez, J. I., Mailloux-Salinas, P., Medina-Contreras, J. M. L., Cruz-Robles, D., & Bravo, G. F. (2015). Effect of Serenoa Repenson oxidative stress, inflammatory and growth factors in obese Wistar rats with benign prostatic hyperplasia. Phytotherapy Research, 29(10), 1525–1531. https://doi.org/10.1002/ptr.5406
• De Monte, C., Carradori, S., Granese, A., Di Pierro, G. B., Leonardo, C., & De Nunzio, C. (2014). Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. BMC Urology, 14(63). https://doi.org/10.1186/1471-2490-14-63
• Debruyne, F., Koch, G., & Boyle, P. (2002). Comparison of a phytotherapeutic agent (Permixon) with an alpha_blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Prog Urol, 12, 384–394.
• Della Loggia, R., Tubaro, A., Sosa, S., Becker, H., Saar, S., & Isaac, O. (1994). The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Medica, 60(6), 516–520. https://doi.org/10.1055/s-2006-959562
• Djavan, B., Fong, Y. K., Chaudry, A., Reissigl, A., Anagnostou, Τ., Bagheri, F., Waldert, M., Fajković, H., Marihart, S., Harik, M., Spaller, S., & Remzi, M. (2005). Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting. World Journal of Urology, 23(4), 253–256. https://doi.org/10.1007/s00345-005-0005-7
• Dmytrenko, O., Arkhypova, M., Starosyla, D., Rybalko, S., Gevorkyan, M., & Galkin, A. Y. (2021). Biological evaluation of medical devices in the form of suppositories for rectal and vaginal use. Innovative Biosystems and Bioengineering, 5(4), 228–237. https://doi.org/10.20535/ibb.2021.5.4.249082
• Dubova, H., Bezusov, A., Biloshytska, O., & Poyedinok, N. (2022). Application of Aroma Precursors in Food Plant Raw Materials: Biotechnological Aspect. Innovative Biosystems and Bioengineering, 6(3-4), 94–109. https://doi.org/10.20535/ibb.2022.6.3-4.267094
• Efstratiou, E., Hussain, A. I., Nigam, P. S., Moore, J. E., Ayub, M. A., & Rao, J. R. (2012). Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complementary Therapies in Clinical Practice, 18(3), 173-1766 https://doi.org/10.1016/j.ctcp.2012.02.003
• Elias, R., Méo, M. D., Vidal-Ollivier, E., Laget, M., Balansard, G., & Dumenil, G. (1990). Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L. Mutagenesis, 5(4), 327-332. https://doi.org/10.1093/mutage/5.4.327
• Final Report on the Safety Assessment of PEG-25 Propylene Glycol Stearate, PEG-75 Propylene Glycol Stearate, PEG-120 Propylene Glycol Stearate, PEG-10 Propylene Glycol, PEG-8 Propylene Glycol Cocoate, and PEG-55 Propylene Glycol Oleate. International Journal of Toxicology, 2001; 20(4_suppl): 13-26. https://doi.org/10.1080/109158101529025561
• Galkin, A., Komar, A., Gorshunov, Y., Besarab, A., & Soloviova, V. (2019). New monoclonal antibodies to the prostate-specific antigen: obtaining and studying biological properties. The Journal of Microbiology, Biotechnology and Food Sciences, 9(3), 573–577. https://doi.org/10.15414/jmbfs.2019/20.9.3.573-577
• Galkin, O. Y., Komar, A. G., & Besarab, O. B. (2019). Different mice inbred strains humoral immune response against human prostate-specific antigen. Ukrainian Biochemical Journal, 91(1), 30-37. https://doi.org/10.15407/ubj91.01.030
• Gijbels, M. J. M., Scheffer, J. J. C., & Svendsen, A. B. (1982). Phthalides in the Essential Oil from Roots of Levisticum officinale. Planta Medica, 44(4), 207–211. https://doi.org/10.1055/s-2007-971448
• Gordon, A. E., & Shaughnessy, A. F. (2003). Saw palmetto for prostate disorders. American Family Physician, 67(6), 1281-1283..
• Goroviy, V.I., Golovenko, V.P., & Kostyuchenko, S.A. (2014). Experience in the use of phytochemical prostate protector Pravenor® in the complex therapy of patients with chronic abacterial prostatitis (category IIIB). Men's Health, 1(48): 114-118.
• Gorpinchenko, I. I., Nurimanov, K. R., & Nedogonova, O. A. (2023). Molecular Mechanisms of Nociception in Chronic Prostatitis. Clinical and Preventive Medicine, (8), 126-133. https://doi.org/10.31612/2616-4868.8.2023.15
• Gorpynchenko, I., Gurzhenko, Y., & Fedorchuk, A. (2013). Study of modification of biochemical parameters of ejaculate in excretory-toxic infertility in men under the influence of the drug Pravenor. Health of Man, (1), 143-147.
• Gorpynchenko, I., Gurzhenko, Y., & Spyrydonenko, V. (2021). analysis of the effectiveness of various types of conservative therapy for chronic bacterial prostatitis. Health of Man, (3), 35-48. https://doi.org/10.30841/2307-5090.3.2021.246209
• Gorpynchenko, I., Romanyuk, M., Aksonov, P., & Kornyenko, O. (2015). Suppositoria Pravenor – a new word in phytoprophylaxis of prostatic diseases. Health of Man, 3(54), 65–69.
• Gorpynchenko, I., & Sytenko, A. (2016). Modern trends in the complex therapy of patients with erectile dysfunction and lower urinary tract symptoms on a background of benign prostatic hyperplasia. Health of Man, 1(56), 114–120.
• Gurzhenko, Y., Spyrydonenko, V., & Fedorchuk, O. (2018). Experience in the application of combined treatment patients with chronic non-spectacular prostate using polycomponent medicine and alpha adrenoblockatоrs. Health of Man, (2), 77–82. https://doi.org/10.30841/2307-5090.2.2018.148977
• Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs, 69(13), 1777–1798. https://doi.org/10.2165/11317010-000000000-00000
• Jambor, T., Arvay, J., Tvrda, E., Kovacik, A., Greifova, H., & Lukac, N. (2021). The effect of Apium graveolens L., Levisticum officinale and Calendula officinalis L. on cell viability, membrane integrity, steroidogenesis, and intercellular communication in mice Leydig cells in vitro. Physiological research, 70(4), 615–625. https://doi.org/10.33549/physiolres.934675
• Jiménez-Medina, E., Garcia-Lora, A., Paco, L., Algarra, I., Collado, A., & Garrido, F. (2006). A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation. BMC Câncer, 6 (119). https://doi.org/10.1186/1471-2407-6-119
• Kalvatchev, Z., Walder, R., & Garzaro, D. (1997). Anti-HIV activity of extracts from Calendula officinalis flowers. Biomedicine & Pharmacotherapy, 51(4), 176-180. https://doi.org/10.1016/S0753-3322(97)85587-4
• Klochko, V., Todosiichuk, T., Lin, W., Kobzysta, O., & Bobyr, V. (2023). Antimicrobial and cytotoxic characteristics of antibiotic streptofungin. Innovative Biosystems and Bioengineering, 7(2), 13–21. https://doi.org/10.20535/ibb.2023.7.2.286158
• Klouchek-Popova, E., Popov, A., Pavlova, N., & Kristeva, S. (1984). Influence of the physiological regeneration and epithelialization using fractions isolated from Calendula officinalis. Acta Physiologica et Pharmacologica Bulgarica, 8(4), 63-67.
• Krasovskyi V., Fedko R., Cherniak T., & Orlovskyi O. (2022). The medicinal properties and the use of the subtropical plants of the Khorol Botanical Garden’s collection (Notice 1). Fitoterapiia. Chasopys – Phytoterapy. Journal, 4, 91–96.
• Kwon, Y. (2019). Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. Food Science and Biotechnology, 28(6), 1599-1606. https://doi.org/10.1007/s10068-019-00605-9
• Llopiz-Guerra, K., Daline, U.R., Ronald, M.H., Valia, L.V.M., Jadira, D.R.J.N., & Karla, R.S. (2024). Importance of Environmental Education in the Context of Natural Sustainability. Natural and Engineering Sciences, 9(1), 57-71.
• Lovecka, P., Lipov, J., Thumova, K., & Macurkova, A. (2017). Characterization of biologically active substances from Calendula officinalis. Current Pharmaceutical Biotechnology, 18(14), 1167-1174. https://doi.org/10.2174/1389201019666180226151910
• Madhavi, M., Sasirooba, T., & Kumar, G. K. (2023). Hiding Sensitive Medical Data Using Simple and Pre-Large Rain Optimization Algorithm through Data Removal for E-Health System. Journal of Internet Services and Information Security, 13(2), 177-192.
• Mansouri, S. (2023). Application of neural networks in the medical field. Journal of Wireless Mobile Networks, Ubiquitous Computing, and Dependable Applications, 14(1), 69-81.
• Metzger, B., Barnes, D. M., & Reed, J. D. (2008). Purple Carrot (Daucus carota L.) Polyacetylenes Decrease Lipopolysaccharide-Induced Expression of Inflammatory Proteins in Macrophage and Endothelial Cells. Journal of Agricultural and Food Chemistry, 56(10), 3554–3560. https://doi.org/10.1021/jf073494t
• Miran, M., Feizabadi, M. M., Kazemian, H., Kardan-Yamchi, J., Monsef-Esfahani, H. R., & Ebrahimi, S. N. (2018). The activity of Levisticum officinale WDJ Koch essential oil against multidrug-resistant Mycobacterium tuberclosis. Iranian journal of microbiology, 10(6), 394-399.
• Mohandas, R., Veena, S., Kirubasri, G., Thusnavis Bella Mary, I., & Udayakumar, R. (2024). Federated Learning with Homomorphic Encryption for Ensuring Privacy in Medical Data. Indian Journal of Information Sources and Services, 14(2), 17–23. https://doi.org/10.51983/ijiss-2024.14.2.03
• Morgia, G., Russo, G. I., Urzì, D., Privitera, S., Castelli, T., Favilla, V., & Cimino, S. (2017). A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Archivio Italiano di Urologia e Andrologia, 89(2), 110-113. https://doi.org/10.4081/aiua.2017.2.110
• Nikitaev, S. V. (2023). Evaluation of vesicoureteral reflux in neurogenic bladder dysfunction and choice of treatment strategy. Clinical and Preventive Medicine, (5), 17-24. https://doi.org/10.31612/2616-4868.5.2023.03
• Penugonda, K., & Lindshield, B. L. (2013). Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients, 5(9), 3617–3633. https://doi.org/10.3390/nu5093617
• Pérez‐Carreón, J. I., Cruz-Jiménez, G., Licea-Vega, J., Popoca, E. A., Fazenda, S. F., & Villa‐Treviño, S. (2002). Genotoxic and anti-genotoxic properties of Calendula officinalis extracts in rat liver cell cultures treated with diethylnitrosamine. Toxicology in Vitro, 16(3), 253–258. https://doi.org/10.1016/s0887-2333(02)00005-x
• Preethi, K. C., Kuttan, G., & Kuttan, R. (2009). Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian Journal of Experimental Biology, 47(2), 113-120.
• Rauf, A., Imran, M., Butt, M. S., Nadeem, M., Peters, D. G., & Mubarak, M. S. (2018). Resveratrol as an anti-cancer agent: A review. Critical Reviews in Food Science and Nutrition, 58(9), 1428–1447. https://doi.org/10.1080/10408398.2016.1263597
• Santos, P. A., Figueiredo, A. C., Oliveira, M. M., Barroso, J. G., Pedro, L. G., Deans, S. G., & Scheffer, J. J. (2005). Growth and essential oil composition of hairy root cultures of Levisticum officinale WDJ Koch (lovage). Plant science, 168(4), 1089-1096. https://doi.org/10.1016/j.plantsci.2004.12.009
• Schinkovitz, A., Stavri, M., Gibbons, S., & Bucar, F. (2008). Antimycobacterial polyacetylenes from Levisticum officinale. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 22(5), 681-684. https://doi.org/10.1002/ptr.2408
• Sirab, N., Robert, G., Fasolo, V., Descazeaud, A., Vacherot, F., Taille, A. D. L., & Terry, S. (2013). Lipidosterolic extract of Serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells. International journal of molecular sciences, 14(7), 14301-14320. https://doi.org/10.3390/ijms140714301
• Stamatiou, K., & Pierris, N. (2013). Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study. Archivio Italiano di Urologia e Andrologia, 85(4), 190-196. https://doi.org/10.4081/aiua.2013.4.190
• Stamatovska, V., & Nakov, G. (2022). Management of apple and grape processing byproducts. A review. Ukrainian Food Journal, 11(4), 518-541. https://doi.org/10.24263/2304-974X-2022-11-4-4
• Sudeep, H. V., Thomas, J. V., & Shyamprasad, K. (2020). A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency. BMC Urology, 20(1), 86. https://doi.org/10.1186/s12894-020-00648-9
• Sudeep, H. V., Venkatakrishna, K., Amrutharaj, B., Anitha, & Shyamprasad, K. (2019). A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model. BMC Complementary and Alternative Medicine, 19(270). https://doi.org/10.1186/s12906-019-2697-z
• Tacklind, J., MacDonald, R., Rutks, I., Stanke, J. U., & Wilt, T. J. (2012). Serenoa repensfor benign prostatic hyperplasia. The Cochrane Library. https://doi.org/10.1002/14651858.cd001423.pub3
• Trivisonno, L. F., Sgarbossa, N., Alvez, G. A., Fieiras, C., Liquitay, C. M. E., Jung, J. H., & Franco, J. V. A. (2021). Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis. Investigative and clinical urology, 62(5), 520. https://doi.org/10.4111/icu.20210254
• Vela-Navarrete, R., Escribano-Burgos, M., Farré, A. L., Garcia-Cardoso, J., Manzarbeitia, F., & Carrasco, C. (2005). Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. The Journal of Urology, 173(2), 507-510. https://doi.org/10.1097/01.ju.0000150533.94952.25
• Yang, J., & Te, A. E. (2005). Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Current Urology Reports, 6(4), 290–295. https://doi.org/10.1007/s11934-005-0026-1
• Yarnell E. (2002). Botanical medicines for the urinary tract. World Journal of Urology, 20(5), 285–293. https://doi.org/10.1007/s00345-002-0293-0
• Yoshikawa, M., Murakami, T., Kishi, A., Kageura, T., & Matsuda, H. (2001). Medicinal flowers. III. Marigold. (1): Hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chemical & Pharmaceutical Bulletin, 49(7), 863–870. https://doi.org/10.1248/cpb.49.863
• Zub, V. O. (2023). Comparative analysis for quality of life of patients with lung, prostate, breast and gastric cancer in Ukraine according to the EORTC QLQ-C30 questionnaire. Clinical and Preventive Medicine, 2, 45-54. https://doi.org/10.31612/2616-4868.2(24).2023.07